Navigation Links
Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall
Date:6/19/2013

NEW YORK, June 19, 2013 /PRNewswire-iReach/ -- Today leading web researchers Change Sciences Group (www.changesciences.com) released all new data ranking Pharmaceutical web sites for usability, engagement, and conversion. The rankings are based on Change Sciences' User Experience Cloud platform, which compares how people experience sites with competitors and with the best sites on the web.

The top three performers are easier to use, more engaging and likelier to convert people overall. The bottom performers have usability problems, lack aspects of design that compel people to explore, and are the least likely among the group to convert prospects to customers. In an unusual case, Merck & Co, Inc. had one of its pharma web sites reach the top of the rankings while one site landed at the bottom. Change Sciences co-founder and partner, Pamela Pavliscak, elaborates, "People who visit a pharma site want more health information than any of the sites currently offer. This results in low engagement across the board. Only a few sites go beyond the information you can get on the package to provide a better experience for pharma sufferers."

Compared to other types of web sites, pharma web site visitors are among the least engaged. No single pharma web site or group of sites stands out as dramatically more engaging than other pharma sites. The opportunity for one site in this study to break away from the rest and really engage users is great, as well as in the greater sphere of pharmaceutical sites.

The UX Cloud platform used to conduct this study makes it possible to mine the web for design patterns that engender trust and compel people to act. Without the UX Cloud, decision-makers are often limited to their own internal data about user experience, which will not reveal whether a competitor's site is easier to use or more engaging, and, perhaps most importantly, will not say why.

To learn more about the UX Cloud visit https://www.changesciences.com/trending/pharmaceutical-web-site-user-experience-2013 and download our free report. The user experience of major medication brands for the following companies are covered in the free report: Bayer Healthcare, Chattem (Sanofi-Aventis), Johnson & Johnson, Merck & Co., Inc., McNeil-PPC, Inc., and Sunovion Pharmaceuticals.

Change Sciences works with Fortune 500s, start-ups, and other smart companies in financial services, tech, entertainment, healthcare and e-commerce, having completed more than 700 projects since 2000, and counting 18 Fortune 100 companies as clients. The idea behind the company is simple: provide enterprise teams with the best data and insights about user experience available. The Change Sciences User Experience Cloud makes it possible to mine a group of sites in a given industry to determine top performing design patterns. Using the UX Cloud teams discover their true usability, engagement and conversion gaps by seeing their numbers in the context of competitors' and the best sites on the web.

Media Contact:

Kelly Nolan, Change Sciences, 888-864-1160 ext 730, kelly@changesciences.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Change Sciences Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
2. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
3. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
4. Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager
5. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
6. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
7. American Oriental Bioengineering Announces Change of Independent Auditors
8. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
9. Aoxing Pharmaceutical Company Announces Management Change
10. Delcath Announced Changes To Board Of Directors
11. OTC Consumer Brand Loyalty Falters in Wake of Branded Recalls, Change in FSA Law, and Recession - Finds Kline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... Getting enough sleep affects much more than energy – it also has mental and physical ... compromise motor reaction time, which can increase the risk of having a car accident. ... from the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... California (PRWEB) , ... April 28, 2017 , ... ... T8 Direct Replace tubes . These lamps offer an instant energy-saving solution for ... need to rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
Breaking Medicine News(10 mins):